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The general stress response of Bacillus 
subtilis and close relatives provides the cell 
with protection from a variety of stresses. 
The upstream component of the 
environmental stress signal transduction 
cascade is activated by the RsbT kinase that 
switches binding partner from a 25S 
macromolecular complex, the stressosome, 
to the RsbU phosphatase. Once the RsbU 
phosphatase is activated by interacting with 
RsbT the alternative sigma factor, σB, 
directs transcription of the general stress 
regulon. Previously, we demonstrated that 
the N-terminal domain of RsbU mediates 
the binding of RsbT. We now describe 
residues in N-RsbU that are crucial to this 
interaction by experimentation both in vitro 
and in vivo. Furthermore, crystal structures 
of the N-RsbU mutants provide a molecular 
explanation for the loss of interaction. 
Finally we also characterise mutants in 
RsbT that affect binding to both RsbU and 
a simplified, binary model of the 
stressosome and thus identify overlapping 
binding surfaces on the RsbT ‘switch’. 
In Gram positive bacteria such as Bacillus 
subtilis, and the human pathogens Listeria 
monocytogenes and Staphylococcus aureus, 
exposure to physical or energy stress results in 
the transcription of the general stress regulon 
(1,2). In B. subtilis the general stress regulon 
comprises approximately 150 genes, (3,4), the 
protein products of which confer multiple 
resistances onto the cell. The general stress 
regulon is controlled by the alternative sigma 
factor, σB (5-9). The availability of σB for 
forming transcriptionally-competent 
complexes with RNA polymerase is regulated 
by a set of signal transduction proteins termed 
Regulators of Sigma B (Rsb). In unstressed 
cells σB is held in a complex with its anti-
sigma factor RsbW and is unable to direct 
RNA polymerase to the promoters of the 
general stress genes. RsbV is the anti-anti 
sigma factor specific to RsbW, and the RsbV-
driven release of σB from the RsbW:σB 
complex allows σB to displace the house-
keeping sigma factor, σA, from RNA 
polymerase holoenzyme (10). RsbW is also a 
protein kinase that is specific for RsbV, and 
phosphorylated RsbV (RsbV-P), which cannot 
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form a complex with RsbW, accumulates in 
unstressed cells (11). Hence it is the 
phosphorylation state of RsbV that determines 
the amount of freely available σB for directing 
the transcription of the general stress regulon. 
 
To activate σB during stress RsbV-P must be 
dephosphorylated. In B. subtilis this is 
achieved by one of two phosphatases 
depending on the type of stress that is being 
experienced by the cell. A decrease in ATP 
concentration leads to the activation of RsbP 
(12,13), either via an interaction with RsbQ or 
as a direct consequence of the product of the 
RsbQ hydrolase activity on RsbP. 
Environmental stresses such as heat or salt 
shock or ethanol treatment (14-16) result 
instead in the activation of RsbU. Like RsbP, 
RsbU belongs to the type 2C serine/threonine 
phosphatase family and RsbU is activated by a 
physical interaction with its partner protein, 
RsbT (16,17). RsbT is a member of the GHKL 
family of kinases/ATPases (18), as is RsbW, 
but unlike RsbW, RsbT does not bind to σ 
factors. In an unstressed cell the RsbU 
activator, RsbT, is believed to be sequestered 
in a supramolecular complex termed the 
stressosome, composed of the RsbT-substrates 
RsbR and RsbS (19) and the RsbR paralogues 
YojH, YqhA and YkoB (19-23). 
Environmental stress results in the stimulation 
of the kinase activity of RsbT towards its 
substrates leading to the dissociation of RsbT 
from the stressosome to activate RsbU and 
consequently σB (17).  
 
The precise mechanism of the interaction and 
activation of RsbU by RsbT remains unclear. 
It is known that RsbU is not a substrate for the 
kinase activity of RsbT (24) and that the 
binding of RsbT to RsbU is entirely localised 
to the N-terminal domain of RsbU (17). The 
crystal structure of this domain, a dimeric 
arrangement of two four-helix bundles, has 
revealed the identities of surface-exposed 
residues that may be key in the binding of 
RsbU to RsbT (17). In some Gram positive 
microbes, for instance the genus 
Staphylococcus, the regulation of RsbU differs 
from the B. subtilis paradigm (25) as these 
bacteria do not encode rsbT in their genomes. 
We report here an investigation into the 
interaction between RsbU and RsbT, and 
demonstrate both in vitro and in vivo the 
precise region on the surface of RsbU crucial 
for the binding of RsbT. In complementary 
studies, we also identify residues in RsbT that 
are critical for the interaction with RsbU and 
the RsbR:RsbS complex. These data establish 
that RsbT utilises a highly-overlapped set of 
amino acids for interacting with RsbU and 
stressosomes. This mutually-exclusive binding 
characteristic is ideal for the propagation of a 
signal transduction cascade. 
 
EXPERIMENTAL PROCEDURES 
 
B. subtilis strains and growth conditions. The 
bacterial strains and plasmids used in this 
study are listed in Table 1. Experiments to 
analyse the influence of various amino acid 
substitutions in RsbU on σB activity were 
performed in derivatives of the Bacillus 
subtilis wild type strain 168 (26). The B. 
subtilis 168 derivative BSM154 (27) that 
carries an internal deletion in rsbU and a σB-
dependent ctc::lacZ transcriptional reporter 
gene fusion was transformed with plasmids 
expressing variants of rsbU. The plasmids 
used to transform BSM154 were derived from 
the B. subtilis non-integrative, self-replicating 
vector pDG148 (28) in which the different 
alleles of rsbU are under control of the 
isopropyl-1-thio-β-D-galactopyranoside (IPTG) 
regulated PSPAC-promoter.  
 
To generate plasmids expressing wild type 
rsbU, and mutated versions thereof, the rsbU 
gene was amplified by PCR using primers 
RsbUWT_f and RsbUWT_r (Supplementary 
Table 1a) with chromosomal DNA from B. 
subtilis 168 as template. The DNA fragment 
was digested with BsaI generating HindIII and 
SalI compatible ends and ligated into HindIII 
and SalI digested pDG148 to produce plasmid 
pJPF01. Four rsbU mutants were generated 
with pJPF01 as template with the respective 
primer pairs (Supplementary Table 1a) using 
the GeneTailor mutagenesis system 
(Invitrogen). The resulting plasmids harboured 
mutated versions of rsbU with the following 
amino acid substitutions (in parentheses) in the 
RsbU protein: pJPF02 (E24K), pJPF03 (Y28I), 
pJPF05 (I74Q) and pJPF06 (I78K). For the 
construction of pJPF07 (S61A), plasmid 
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pETRsbUS61A was used as a template for 
amplification and the PCR product cloned into 
pDG148 using the same restriction enzymes as 
for pJPF01. The correct sequence of all rsbU 
inserts was confirmed by sequencing prior to 
transformation into B. subtilis BSM154 
generating strains BSGH01, BSGH02, 
BSGH03, BSGH05, BSGH06 and BSGH07, 
respectively. Selection of B. subtilis 
transformants was performed on LB agar 
plates supplemented with phleomycin at a 
concentration of 5 μg ml-1.  
 
B. subtilis cells were routinely grown at 37 °C 
under vigorous shaking in a synthetic medium 
(29) supplemented with 0.05 % (w/v) glucose 
as a carbon source and L-tryptophan (0.78 
mM). The cultures for the stress-experiments 
were inoculated from overnight cultures 
propagated in synthetic medium to an optical 
density at 500 nm of 0.05. If appropriate, the 
overnight culture was supplemented with 
kanamycin (20 µg ml-1) and phleomycin (0.2 
µg ml-1). Expression of the plasmid-encoded 
variants of rsbU was induced by the addition 
of IPTG to a final concentration of 1 mM. 
Addition of IPTG did not influence the growth 
of B. subtilis; an example growth curve is 
shown for strain BSM151 (grey line, Figure 
2). To activate σB via the RsbU-dependent 
environmental stress pathway, ethanol (4% v/v 
final concentration) was added to 
exponentially growing cells (A500 of 0.3, t=0). 
To determine the β-galactosidase activity of 
the ctc::lacZ transcriptional reporter gene 
fusion, and hence infer σB activity, 1 ml 
aliquots of cell cultures were harvested at 
various time points and assayed for β-
galactosidase enzyme activity as described 
previously (14,30). In order to exclude the 
possibility that a lack of σΒ activity in 
response to ethanol could be correlated to the 
absence of RsbU in these B. subtilis strains, 
the expression of RsbU in vivo was monitored 
by Western blotting cell extracts with an anti-
RsbU antibody (31). The blot confirmed that 
there was no difference in the cellular levels of 
plasmid-expressed RsbU wildtype and mutant 
proteins (data not shown). 
 
Site directed mutagenesis. Plasmids containing 
N-rsbU, rsbU and rsbT, the construction of 
which has been described previously (17,32), 
served as templates for site directed 
mutagenesis by the QuikChange procedure 
(Stratagene). Individual amino acid mutations 
were introduced into rsbU, N-rsbU and rsbT 
by the addition of specific complementary 
oligonucleotide primers to the mutagenising 
PCR mix (Supplementary Table 1b). After 
amplification by PCR the template DNA was 
removed by digestion with DpnI and the 
remaining DNA was used to transform E. coli 
DH5α. Correct mutations were confirmed by 
DNA sequencing. In the N-rsbU construct the 
following amino acids substitutions were made: 
E24K, Y28I, R35D, I74Q, I78K, M82Y and A83S. 
These substitutions were selected because 
these amino acids are conserved in RsbU in 
those bacteria that code for RsbT, and are not 
necessarily conserved in bacteria that do not 
encode for RsbT. These residues are also 
clustered together on the surface of the 
structure of N-RsbU and are therefore 
available for potential interactions with RsbT. 
Three other, conserved amino acids in the 
immediate vicinity of the original target list 
were each converted to alanine in N-RsbU: 
Y18, Q31 and S34. In addition, one surface-
exposed residue that is remote from this region, 
S61, was also converted to alanine. Only 
mutations E24K, Y28I, Q31A, S61A, I74Q and 
I78K were also mutated in full length rsbU. 
The mutations that were made in RsbT were 
based on the work of Woodbury et al (33), 
who had previously mutated polar and charged 
amino acids in RsbT to alanine in assessing 
the roles that these amino acids played in the 
induction of σB activity. E12, D14, R19, Q20, D35, 
Q36 were each mutated to alanine by 
QuikChange procedures in addition to a 
double alanine substitution of R23-N24 and a 
triple alanine replacement of V107-K108-R109.  
 
Protein expression and purification. Plasmids 
directing overexpression of wild type and 
mutant RsbU and RsbT proteins were 
transformed into E. coli strain BL21 (DE3), 
and the resulting E. coli strains were grown in 
1 litre of LB media to an optical density at 600 
nm of 0.4. Expression of recombinant proteins 
was induced by the addition of IPTG to the 
culture to a final concentration of 1 mM. Cells 
were harvested three hours after induction by 
centrifugation for 20 minutes at 4000 rpm and 
the cell pellets were resuspended in 20 ml of a 
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lysis buffer containing 20 mM Tris.HCl pH 
8.0, 1 mM DTT and lysed by sonication. 
Soluble proteins were separated from cell 
debris by centrifugation at 15000 rpm for 1 
hour. For RsbU and N-RsbU proteins filtered 
supernatant was loaded onto a 10 ml Q-
sepharose anion exchange column (G. E. 
Healthcare) pre-equilibrated with lysis buffer. 
Bound proteins were eluted over a 50 ml linear 
gradient of lysis buffer supplemented with 1 M 
NaCl. The fractions containing RsbU proteins 
were identified by SDS-PAGE and 
concentrated for loading onto Superdex 75 (N-
RsbU) or Superdex 200 (RsbU) gel filtration 
columns (G. E. Healthcare). Fractions 
containing RsbU proteins were concentrated to 
approximately 5 mg ml-1, supplemented with 
glycerol to a final concentration of 20 %, and 
stored at -80 ˚C in 50 μl aliquots.  
 
For the ease of purification, RsbT was over-
produced as a glutathione-S-transferase fusion 
with rsbT cloned immediately downstream of 
gst in pGEX6p2 (G. E. Healthcare). Filtered 
supernatants of GST-RsbT proteins were 
loaded onto a 10 ml glutathione sepharose 
column (G. E. Healthcare) equilibrated with 
buffer A (20 mM Tris.HCl pH 8.0, 300 mM 
NaCl, 1 mM DTT, and 0.1 mM ATP). After 
extensive washing with buffer A, bound 
proteins were eluted in buffer A supplemented 
with 50 mM reduced glutathione. GST was 
cleaved from the RsbT fusion protein by 
incubation with 3C protease at 4 °C overnight. 
RsbT was purified further by gel filtration 
chromatography. Pure RsbT was concentrated 
to approximately 1 mg ml-1, supplemented 
with 20 % glycerol, and stored at -80 ˚C in 50 
μl aliquots. 
 
Native gel electrophoresis. N-RsbU:RsbT 
binding experiments were performed in a 
buffer of 20 mM Tris.HCl pH 8.0, 150 mM 
NaCl, and 0.1 mM ATP. RsbT and N-RsbU 
proteins were incubated at 30 ˚C for ten 
minutes prior to analysis by non-denaturing 
polyacrylamide gel electrophoresis and 
subsequent visualisation by Coomassie blue 
staining.  
 
Measurement of phosphatase activity. RsbV-P, 
the phosphatase substrate of RsbU, was 
prepared as described previously (19). The 
dephosphorylation reactions were performed 
in a buffer of 50 mM Tris.HCl pH 7.5, 50 mM 
KCl, 10 mM MgCl2, 1 mM MnCl2, 1 mM 
DTT, and 100 μM ATP. 30 μM RsbV-P was 
incubated with 1 μM RsbU and 1 μM RsbT 
proteins. The rate of dephosphorylation of 
RsbV-P was measured by removing 20 μl 
samples at various time intervals and by 
stopping the reaction by the addition of 10 μl 
of stop buffer (50 % glycerol, 300 mM DTT, 
200 mM EDTA and 0.1 % bromophenol blue) 
and subsequent storage on ice until all samples 
were ready for analysis by native gel 
electrophoresis and Coomassie blue staining. 
RsbV-P and RsbV bands are separated easily 
on a 12 % acrylamide native gel (11). The gels 
were scanned and intensities of the bands 
corresponding to the appearance of RsbV were 
measured with Scion Image software (Scion 
corp.). The phosphatase activity of the RsbU 
mutants and wild type RsbU in the presence of 
mutants of RsbT were then compared to that 
of wild type RsbU in the presence of wild type 
RsbT. 
 
Surface plasmon resonance. Surface plasmon 
resonance studies were carried out with the 
BIAcore 2000 system (BIAcore, Uppsala, 
Sweden). Mutant N-RsbU proteins were 
immobilised on CM5 gold surfaces by amine 
coupling using the protocol provided by the 
manufacturer. Wildtype N-RsbU was 
immobilised on each chip as a positive control. 
Briefly, N-RsbU proteins were diluted into a 
buffer of 50 mM sodium acetate at pH 5.0 to a 
final concentration of 25 μg ml-1, and then 
injected onto the activated CM5 surface at 5 μl 
min-1 in phosphate-buffered saline running 
buffer until a final resonance value of ~ 500 
response units was achieved. The sensor 
surface was then deactivated by blocking with 
1 M ethanolamine. A range of concentrations 
of RsbT analyte in running buffer of 50 mM 
Tris.HCl pH 7.5, 50 mM KCl, 10 mM MgCl2, 
1 mM MnCl2, 1 mM DTT, and 100 μM ATP 
(the same buffer that is used in the RsbU 
phosphatase dephosphorylation reaction) was 
injected onto the biosensor chip for 1 minute 
at a rate of 30 μl min-1. Each experiment was 
replicated on at least two separate occasions. 
The surface plasmon resonance data for all N-
RsbU proteins were analysed using the 
BIAevaluation software (BIAcore, Uppsala, 
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Sweden) and SigmaPlot (Systat). The data 
were plotted as a binding curve to which a 1:1 
Langmuir binding interaction, describing 1:1 
binding between an analyte A and a ligand B: 
A + B ↔AB (34), could be modelled. The 
reliability of the fit of the model to the data is 
such that R2 values of no less than 0.985 were 
obtained for all the individual data sets. 
 
Crystallographic methods. Crystals of mutants 
of N-RsbU suitable for X-ray diffraction were 
grown by hanging drop vapour diffusion. 
Crystals of approximately 200 μm in diameter 
appeared in a few days for N-RsbUE24K, N-
RsbUY28I and N-RsbUI78K in a mother liquor of 
10 % PEG 20000, 100 mM MES, pH 6.5, 
conditions similar to that of wildtype N-RsbU 
(35). Crystals of N-RsbUI74Q were not obtained 
from our crystallisation screening procedures. 
Single crystals were soaked in a cryoprotectant 
of mother liquor supplemented with 30 % PEG 
400 for ten seconds before flash freezing in 
liquid nitrogen in preparation for diffraction 
analysis. 
 
Analysis of the diffraction data from crystals 
of N-RsbUY28I and N-RsbUI78K revealed that 
they had retained the N-RsbUWT space group 
and unit cell dimensions with one protein 
molecule in the asymmetric unit (Table 2). N-
RsbUE24K crystallised in space group C2 with 
unit cell dimensions a = 100.2 Å, b = 47.8 Å, c 
= 94.7 Å, β = 104.4 ° with 5 copies of N-
RsbUE24K in the asymmetric unit. All 
diffraction data sets were integrated and scaled 
with MOSFLM and SCALA and all 
subsequent analyses were performed with 
programs from the CCP4 suite (36). After 
rigid body refinement in REFMAC (37) 
inspection of electron density maps of N-
RsbUY28I and N-RsbUI78K confirmed the amino 
acid substitutions. Rounds of manual 
correction to the models with COOT (38) were 
interspersed with refinement in REFMAC 
until refinement converged (Table 2).  
 
The structure of N-RsbUE24K was solved by 
molecular replacement with MOLREP (39). 
With a dimer of N-RsbUWT as the search 
model, 2 independent dimers in the 
asymmetric unit were found. Four obvious 
solutions were found using a monomer as 
search model, but with a lower correlation co-
efficient and a higher Rfactor in comparison to 
the solution obtained with the dimer as search 
model. A fifth monomer was, in retrospect, 
correctly positioned but the correlation co-
efficient and the Rfactor did not improve. The 
self rotation function revealed the presence of 
non-origin peaks >70 % of the origin height on 
both κ = 90 ° and κ = 72 °, consistent with the 
presence of 4 or 5 molecules in the 
asymmetric unit, respectively. Analysis of the 
electron density maps calculated after 
correctly positioning 2 dimers of N-RsbUE24K 
revealed features consistent with a 5th copy of 
N-RsbUE24K adjacent to the crystallographic b 
axis, forming a dimer of N-RsbUE24K around 
this dyad. Using phase estimates calculated 
from the molecular replacement solution, 
almost the entire structure of each of the five 
copies of N-RsbUE24K was traced with the 
auto-building option in ARP/wARP (40). 
Further rounds of re-building and refinement 
continued in COOT and REFMAC until 
convergence (Table 2). 
 
RESULTS 
 
Native PAGE analysis of N-RsbU mutants. 
The interaction between RsbU and RsbT at a 
1:2 molar ratio results in a 40 fold increase in 
RsbU phosphatase activity in vitro (17). This 
stimulation is an absolute requirement of the 
induction of σB activity and, therefore, the 
response of B. subtilis to environmental stress. 
Mutation of residues in RsbU which result in a 
disruption of the interaction with RsbT should, 
therefore, inhibit σB induction. We predicted 
previously that residues located in two 
contiguous patches on either side of the N-
RsbU dimer interface may be involved in the 
interaction between N-RsbU and RsbT (17). 
Many of these amino acids are conserved 
across bacterial species that encode RsbT (e.g. 
members of the genera Bacillus and Listeria) 
but are not necessarily conserved in those 
bacteria that do not encode RsbT (e.g. the 
genus Staphylococcus), in which the 
regulation of RsbU differs from that in B. 
subtilis. In order to assess the influence of 
each residue on RsbT-binding, twelve new 
constructs of N-RsbU were created by site 
directed mutagenesis. Wherever possible the B. 
subtilis RsbU amino acid sequence was 
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replaced with the equivalent from S. aureus. 
The purified N-RsbU mutant proteins were 
assessed for RsbT-binding by a standard non-
denaturing poly-acrylamide gel electrophoresis 
assay (11,17).  
 
RsbT alone did not electrophorese as a sharp 
band in a native gel and was localised to the 
well, whereas wild type N-RsbU formed a 
single sharp band towards the bottom of the 
gel (Figure 1). An additional band was 
observed when RsbT was mixed with N-
RsbUWT that migrated slower through the gel 
than N-RsbUWT alone, corresponding to a 
complex between RsbT:N-RsbUWT that is 
stable under the conditions of gel 
electrophoresis (11). In a similar fashion the 
binding of mutant N-RsbU proteins to RsbT 
was assessed. Should the mutation have a 
serious and detrimental effect on complex 
formation, the additional band (corresponding 
to the complex) will not be detectable. This 
method of analysis highlighted four mutants – 
N-RsbUE24K, N-RsbUY28I, N-RsbUI74Q and N-
RsbUI78K - where a complex between RsbT 
and the mutant N-RsbU proteins could not be 
detected (Figure 1). Four other mutants - N-
RsbUY18A, N-RsbUR35D, N-RsbUM82Y and N-
RsbUA83S - could each still form a complex 
with RsbT that could be visualised on a native 
gel (Figure 1), indicating that amino acids Y18, 
R35, M82 and A83 are not absolutely critical to 
the RsbU:RsbT interaction. The native gel 
binding studies provided only a qualitative 
assessment of which surface-exposed amino 
acids in N-RsbU are important for the 
interaction with RsbT. Furthermore, the poor 
electrophoretic characteristics of RsbT require 
the use of a more robust analytical technique, 
such as surface plasmon resonance, to confirm 
and to quantify these interactions.  
 
Surface plasmon resonance analysis. Surface 
plasmon resonance was used to quantify the 
binding of RsbT (as the analyte) to N-RsbU as 
the ligand. Consistent with the native gel 
binding assay, the N-RsbU mutants E24K, Y28I, 
I74Q and I78K immobilised on the BIAcore 
chip did not respond to the RsbT-analyte 
regardless of analyte concentration used. The 
remaining mutants of N-RsbU, including a 
mutation of S61A (S61 is surface-exposed but 
remote from the projected RsbT binding site), 
all responded to RsbT similar to wild type N-
RsbU in both the magnitude and the kinetics 
of response.  
 
The SPR data and calculated Kd values 
between RsbT and all N-RsbU proteins are 
summarised in Table 3. For the wildtype N-
RsbU:RsbT interaction, a simple 1:1 Langmuir 
binding model yielded a Kd of 2.1 μM. The 
weak interaction is ideal for a transient 
signalling system dependent upon alternative 
protein:protein interactions for signal 
transduction. Where dissociation constants 
could be calculated for the mutant N-
RsbU:RsbT interactions, the Kd differ only by 
approximately ±two-fold from the wildtype. 
For instance, the mutation to alanine of Q31 
and S34 both resulted in a slight reduction in 
the Kd of the N-RsbU:RsbT interaction, to 
0.98 μM and 0.91 μM respectively. These 
values indicate that the complex formed with 
the mutant N-RsbU proteins is marginally 
more stable than for wild type, but the ~two-
fold difference is unlikely to have a significant 
physiological effect.  
 
Effect of mutations on RsbU phosphatase 
activity. To assess whether the mutations of N-
RsbU that disrupt most severely the complex 
with RsbT can also prevent activation of RsbU 
phosphatase activity, we made a series of 
mutants of full-length RsbU. Wild type and 
mutant full-length RsbU proteins were each 
added to RsbV-P dephosphorylation reactions 
in the absence and presence of equimolar 
RsbT. The addition of RsbT to RsbUWT 
resulted in a 13-fold increase in the rate of 
RsbV-P dephosphorylation (Table 4). The 
difference in the extent of activation seen here 
in comparison to that previously reported by 
us (17) is presumably a reflection of the 
different ratios of RsbU:RsbT used in the two 
studies. The mutant RsbU proteins in the 
absence of RsbT all had low activities, similar 
to that of wildtype RsbU in the absence of 
RsbT. For mutations Q31A and S61A, the 
activation of RsbU phosphatase function in the 
presence of RsbT approached or exceeded the 
activation observed with wildtype RsbU. The 
~1.8-fold greater increase in RsbU activity 
with the Q31A mutant in comparison to 
wildtype is consistent with our SPR data, 
which revealed a ~2-fold decrease in Kd for the 
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N-RsbUQ31A:RsbT interaction in comparison to 
the wildtype. By contrast, the addition of RsbT 
to RsbUE24K, RsbUY28I, RsbUI74Q and RsbUI78K 
did not stimulate at all the rate of RsbV-P 
dephosphorylation (Table 4). Taken together, 
the results of these in vitro experiments 
indicate that the mutations E24K, Y28I, I74Q and 
I78K of RsbU are not only sufficient to render 
undetectable by our experimental procedures 
the RsbU:RsbT interaction but also can no 
longer stimulate the phosphatase activity of 
RsbU.  
 
Effects of RsbU mutations in vivo. If the 
mutations E24K, Y28I, I74Q and I78K of RsbU 
truly disable the interaction with RsbT in vitro 
then these mutations should also prevent the 
activation of σB upon environmental stress in 
vivo. To test this experimentally, the RsbU 
mutants E24K, Y28I, I74Q and I78K were cloned 
by PCR. In addition, S61A was created; S61 is 
surface-exposed but away from the proposed 
RsbT-binding site in RsbU. These RsbU 
variants were placed under the control of the 
IPTG-inducible promoter, PSPAC into a non-
integrative plasmid and transformed onto an 
rsbU-deleted strain of B. subtilis that also 
carries a σB-dependent lacZ reporter gene 
fusion. The environmental stress response was 
induced in these strains by the addition of 
ethanol to the growth medium and σB activity 
inferred from that of LacZ. 
 
Only the B. subtilis strain carrying the lacZ 
reporter and a chromosomal copy of rsbUWT 
displayed good β-galactosidase, and hence σB, 
activity in the absence of IPTG on the 
imposition of environmental stress (Figure 2a). 
The β-galactosidase activity peaked within 
~20 minutes of the addition of ethanol to the 
growth medium and the transient stress 
response was, in effect, complete after a 
further 30 minutes. Other than this strain, only 
those strains carrying plasmid-encoded 
RsbUWT or RsbUS61A displayed good β-
galactosidase activity in the presence of IPTG 
(Figure 2b). The magnitude and kinetics of 
the σB response in these two strains are similar 
to that of the parental strain with a 
chromosomal copy of rsbUWT. The strains 
carrying the RsbU mutations E24K, Y28I, I74Q 
and I78K do not respond to environmental 
stress in vivo (Figure 2b). Therefore, these 
mutations prevent the activation of σB and 
highlight the important role that these amino 
acids play in RsbT-recruitment and RsbU-
activation. These observations are perfectly 
consistent with our findings in vitro where it is 
no longer possible to detect the interaction 
between RsbU and RsbT and the subsequent 
stimulation of the phosphatase activity of 
RsbU with these four mutants of RsbU.  
 
Structural analysis. To understand further the 
molecular effect of the mutations E24K, Y28I, 
I74Q, and I78K in the N-terminal domain of 
RsbU we solved the structure of three of these 
four mutant N-RsbU proteins by X-ray 
crystallography. Residues E24, Y28, I74 and I78 
of RsbU are located in a distinct region on the 
surface of N-RsbU, a region we will term the 
RsbT binding pocket (Figure 3a). N-RsbUI74Q 
did not crystallise despite repeated attempts. 
The structures of N-RsbUE24K (Figure 3b), N-
RsbUY28I (Figure 3c) and N-RsbUI78K (Figure 
3d) were solved by molecular replacement 
using the wild type N-RsbU as the molecular 
replacement search model, and refined against 
diffraction data extending to 1.85 Å for N-
RsbUE24K and 1.95 Å for N-RsbUY28I and N-
RsbUI78K. Details of the data collection and 
refinement statistics are given in Table 2. 
 
All three mutant N-RsbU structures are highly 
similar to the wildtype structure previously 
solved, comprising 4 α-helices arranged in a 
rough L-shape. This fold is a variant on the 
“X” nomenclature of 4-helical bundles (41). 
Two N-RsbU protomers form an 8-helical 
dimeric bundle, in which the C-terminal 
helices are domain-swapped, the significance 
of which, if any, is unknown. In N-RsbUY28I 
and N-RsbUI78K, one N-RsbU monomer 
crystallises around the crystallographic a axis 
to form a dimer, as in wildtype. For N-
RsbUE24K, which crystallised in spacegroup C2, 
one dimer is formed across the 
crystallographic b axis and there are two other, 
independent dimers in the asymmetric unit. 
Overall, the mutations introduced to N-RsbU 
do not change significantly the main chain 
conformation. For both N-RsbUY28I and N-
RsbUI78K the rmsd in Cα position in 
comparison to N-RsbUWT is < 0.20 Å. 
Therefore, only the local environment of the 
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mutation is affected to accommodate the 
amino acid change.  
 
Within the N-RsbUE24K asymmetric unit, the 
five individual monomers can be 
superimposed with rmsd in equivalent Cα 
positions ranging from 0.24 Å (molecules B 
and E) to 0.47 Å (molecules A and C). Similar 
values are obtained for the comparison of N-
RsbUE24K to N-RsbUWT. The largest 
differences in structure, shifts of up to 1.5 Å in 
backbone position in 4 of the 5 independent 
molecules, occur in the immediate vicinity of 
residue 24. E24 is found at the N-terminal end 
of α-helix 2 in N-RsbUWT. In the N-RsbUE24K 
crystal form K24 participates in crystal contacts, 
including a direct hydrogen bond between K24 
in one molecule and E75 in another. Therefore, 
the re-modelling of the local structure to E24K 
may occur purely as a consequence of crystal 
contacts in the new crystal form.  
 
The inability to detect an interaction between 
RsbU and RsbT with the mutations E24K, Y28I 
and I78K in RsbU may be explained by 
comparing the structures of these mutant N-
RsbU proteins to that of wildtype (Figure 3b-
d). The mutations E24K, Y28I and I78K all lead 
to the mutant side chain conformations 
protruding into the RsbT binding pocket, 
partially blocking the site for RsbT docking. 
Moreover, potential electrostatic interactions 
between the acidic residue E24 of RsbU and 
basic residues of RsbT might be disrupted by 
mutation to the basic amino acid lysine. 
Similarly, hydrophobic contacts from I78 of 
RsbU to RsbT may be affected by the 
introduction of lysine at this position. Finally, 
the removal of the tyrosyl hydroxyl group at 
Y28 and the reduction in sidechain volume 
from tyrosine to isoleucine may affect contacts 
between RsbU and RsbT. 
 
The crystal structure of N-RsbUWT revealed 
that residues E24 and Y28, and residues I74 and 
I78 are on adjacent turns of α-helices 2 and 4 
and form 2 surface-exposed ridges on either 
side of the dimer interface. This initial screen 
for RsbU mutants affected in RsbT-binding 
suggested that amino acids in N-RsbU 
between these two, parallel patches might also 
be involved in the RsbT:RsbU interaction. In 
particular the side chains of Q31 and E75 are 
adjacent to one another but do not participate 
in any inter- or intra-molecular interactions 
(other than crystal contacts) whereas S34 has a 
structural role in the stabilisation of α-helices 
2 and 4. Accordingly Q31, S34 and E75 were 
each mutated to alanine, since each of these 
three amino acids are homologous in the 
Staphylococci. The ability of the three N-RsbU 
mutants to form complexes with RsbT was 
judged by native-PAGE and SPR. In all three 
cases a band corresponding to the RsbT:N-
RsbU complex could still be seen (Figure 1), 
and calculated Kd values differ only by ~2 fold 
from wildtype (Table 3). Although these 
residues are flanked by key, complex-
mediating amino acids, mutation to alanine of 
Q31, S34 and E75 suggests that they do not play 
critical roles in the RsbU:RsbT interaction. 
Less conservative substitutions may be 
required to reveal any direct involvement in 
RsbU:RsbT complex formation. 
 
Partner-switching of RsbT. Although a 
complex between RsbU and RsbT can be 
visualised by native gels and quantified by 
SPR, the interaction between RsbU and RsbT, 
in our hands, has proved to be insufficiently 
tight for the crystallisation of RsbU:RsbT 
complexes for structural studies. To 
understand how RsbT binds to both RsbU and 
the RsbR:RsbS complex, it has been necessary 
to devise an alternative strategy. In a previous 
study by Woodbury et al charged residues in 
RsbT were mutated to alanine and the 
response to stress examined in vivo (33). From 
this study several residues were proposed to 
play roles in the interaction of RsbT with 
RsbU because of a reduction in σB activity on 
ethanol stress. However, these studies could 
not determine whether the RsbT variants were 
also affected in ‘stressosome’ binding: RsbT 
interacts with both the stressosome and RsbU, 
before and during stress, respectively. To 
expand further on the study of Woodbury et al 
we have made mutations in rsbT that 
encompass all of the amino acids suggested by 
Woodbury (33) that are involved in the 
interaction of RsbT with RsbU (except for the 
T13 mutant that is likely affected in ATP-
binding) and tested the ability of these RsbT 
mutants to bind to the RsbR:RsbS complex 
and RsbU.  
8
 Three of the constructs that were made, 
RsbTD14A (derived from T3), RsbTD35A 
(derivative of T7), and RsbTV107A-K108A-R109A 
(T16), expressed at very low levels in E. coli 
and thus were not studied further. Woodbury 
et al reported previously that the rsbT3 mutant, 
from which D14A is derived, failed to activate 
σB but that it also accumulated poorly in B. 
subtilis (33). Perhaps the D14A mutation in 
RsbT reduces protein stability. For the purpose 
of this study we focused on the remaining 
RsbT mutants, RsbTE12A (T3 derivative), 
RsbTR19A (T4 derivative), RsbTQ20A (T4 
derivative), RsbTR23A-N24A (T5), and RsbTQ36A 
(T7 derivative), which were purified to 
electrophoretic homogeneity. Mutant RsbT 
proteins were mixed with the purified 
RsbR:RsbS complex before unbound RsbT 
was separated by gel filtration chromatography. 
Wildtype RsbT binds to RsbR:RsbS and all 
three proteins co-elute in the void volume of 
the gel filtration column (Figure 4a). Of the 
RsbT mutants, RsbTE12A, RsbTQ20A and 
RsbTQ36A each retained the ability to interact 
with the RsbR:RsbS binding partner and co-
eluted with RsbR:RsbS similarly to wildtype 
RsbT (Figure 4a). On the other hand, 
RsbTR19A and RsbTR23A-N24A each eluted as 
monomeric proteins of ~14 kDa and were 
well-separated from the much larger 
stressosome. These proteins, which we 
presume are folded correctly, are severely 
impaired in RsbR:RsbS-binding and may 
therefore identify key amino acids in this 
interaction.  
 
A native PAGE assay was also used to study 
the interaction of N-RsbU with the RsbT 
mutants. Unlike wild type RsbT which 
electrophoreses poorly into native gels, 
RsbTR19A, RsbTR23A-N24A and RsbTQ36A each 
migrate into the gel (Figure 4b) and RsbTE12A 
does not enter the gel at all. Perhaps these 
differences in electrophoretic behaviour reflect 
a change in the overall charge of the protein. 
The native gel analysis indicated that no 
RsbT:N-RsbU complexes could be detected on 
mutation to alanine of RsbT residues E12, R19 
and R23-N24. Only RsbTQ20A and RsbTQ36A 
retained the ability to form a complex with N-
RsbU. These results indicate that the mutations 
in RsbT that appear to disrupt the interaction 
with RsbU are also sufficient to disrupt the 
interaction with the RsbR:RsbS complex. The 
sole exception is RsbTE12A, which does not 
appear to bind to N-RsbU in the native gel 
assay, but can still bind to RsbR:RsbS.  
 
In order to confirm the roles of RsbT residues 
E12, R19 and R23-N24 in the interaction with 
RsbU we performed SPR analyses with N-
RsbUWT immobilised on the SPR chip and 
used the mutant RsbT proteins as analytes 
(Table 3). For RsbTQ20A and RsbTQ36A the 
measured Kd values were 2.1 μM and 4.0 μM 
in comparison to the wildtype value of 2.14 
μM. No binding to N-RsbU could be detected 
for RsbTR19A, RsbTR23A-N24A, observations that 
are consistent with the results from the native 
gel assay. However, we could detect N-RsbU 
binding to RsbTE12A, with a Kd of 3.8 μM, 
indicating that a complex is formed between 
RsbU and RsbTE12A, albeit one that is 
approximately 75 % weaker than that of 
wildtype.  
 
Finally, we assessed the RsbU-activation 
properties of the RsbT mutants in the RsbV-P 
dephosphorylation assay (Table 4). Only 
RsbTQ20A and RsbTQ36A retained the ability to 
trigger the RsbU phosphatase activity, both of 
which stimulated RsbU phosphatase activity to 
levels that exceeded that of wildtype RsbT. 
Intriguingly, RsbTE12A did not activate RsbU, 
despite an apparent Kd for its binding with 
RsbT that was slightly lower than that of the 
interaction between RsbT and RsbTQ36A. 
Perhaps the role of RsbTE12 in the regulation of 
RsbU is more complex than some of the other 
amino acids, and may be involved, for instance, 
in signalling conformational changes within 
RsbU that lead to its activation.  
 
DISCUSSION 
 
Reversible phosphorylation of proteins is one 
of the most prevalent biological control 
mechanisms (42). The general stress response 
of B. subtilis and close relatives is 
underpinned by phosphoryl transfer and by 
transient protein:protein interactions. The 
interplay between the RNA polymerase sigma 
factor subunit, σB, and its anti-sigma factor, 
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RsbW and anti-anti-sigma factor, RsbV, a 
phenomenon termed ‘partner-switching’, is 
regulated by phosphorylation and protein 
complex remodelling (Figure 5). Here, we 
report an analysis of the partner-switching of 
the RsbW-homologue, RsbT, with its 
alternative binding partners RsbU and a 
simplified model of the stressosome, the 
RsbR:RsbS complex. The experimental design 
utilised reflects the absence of any high 
resolution structural data on the complexes 
that RsbT forms with its binding partners. 
 
Previously we have determined that RsbT-
binding to RsbU is mediated by the N-terminal 
domain of RsbU (19). In this report we have 
identified and characterised key residues in 
RsbU that are required for the interaction with 
RsbT. These data complement those of Murray 
et al who identified three surface-exposed 
residues in N-RsbR that, in the context of the 
RsbR:RsbS complex, also cannot detectably 
bind RsbT (32). The determination of the 
structure of N-RsbR revealed, quite 
unexpectedly, that N-RsbR and N-RsbU are 
structurally homologous (32). N-RsbU can be 
superimposed on (the core of) N-RsbR with a 
rmsd on equivalent Cα atoms of 3 Å. This 
structural homology conserves the functional 
ability for these protein domains to interact 
with RsbT. The three N-RsbR residues 
affected in RsbT-binding, E60, K82 and E126 
have spatial counterparts in N-RsbU; L27, E45 
and E75, respectively. L27 and E75 are each just 
a single amino acid away from residues Y28 
and I74 that this study has revealed are central 
to the interaction of RsbU with RsbT (Figure 
3e-f). Although the region that RsbT binds to 
in RsbR is structurally equivalent to that in 
RsbU, the physicochemical properties of the 
amino acids involved are quite different. The 
glutamic acids at positions 60 and 126 in RsbR 
have near-spatial equivalents in RsbU at 28 
and 74, but the chemistries of tyrosine and 
isoleucine at these positions are not equivalent 
to glutamate. Therefore, only the global site 
and not the specific mode of interaction of 
RsbT to RsbU and RsbR are conserved. 
Perhaps RsbRE60 and RsbUE24 are functionally 
equivalent, each positioned so as to interact 
with either RsbTR19 or RsbTR23. These two 
arginines are extremely well conserved across 
RsbT orthologues in those organisms coding 
for the rsbRST gene cluster (43), underlining 
their functional significance.  
 
From the data we present it is clear that 
mutation of residues in the RsbT binding 
region of RsbU diminishes or renders 
undetectable RsbU-binding to RsbT. For RsbU 
it appears that the loss of RsbT binding ability 
is due to a combination of the “filling” of the 
RsbT binding pocket by amino acid side 
chains, and the removal of possible charge-
charge interactions between residues of RsbU 
and RsbT. The crystallographic studies reveal, 
in the 3 structures solved, that the overall fold 
of the RsbT-binding domain in N-RsbU is 
barely changed by the mutagenesis. The 
structural studies are compatible with our 
biochemical data and with our in vivo data, 
where σB activity cannot be induced in these 
mutants. Therefore, all our data, from quite 
disparate experimental procedures, are self-
consistent and point to crucial roles for RsbU 
residues E24, Y28, I74 and I78 in the RsbU:RsbT 
interaction. 
 
We have also investigated whether mutations 
in RsbT that disrupt the interaction with RsbU 
also disrupt the interaction with the 
RsbR:RsbS complex, a simplified model of the 
stressosome. In the original analysis by 
Woodbury et al (33), the RsbT mutants Q20A 
and Q36A were both constructed as ‘double 
mutants’, as R19A-Q20A and D35A-Q36A 
(called T4 and T7, respectively). From our 
results, the effect on σB activation caused by 
T4 is due solely to R19A, which we have shown 
here is defective in RsbR:RsbS and RsbU 
binding and RsbU activation (as is R23A-N24A, 
T5) whereas Q20A behaves like wildtype. For 
T7, the effect on σB activation is not due to 
Q36A, which also behaves as though wildtype, 
but more likely to D35A, which we have not 
been able to study. Taken together, our data 
indicate that RsbT utilises overlapping 
surfaces to bind to its two alternative binding 
partners, perhaps explaining why no 
constitutively active mutant was obtained in 
the genetic analysis by Woodbury et al (33). 
The behaviour of RsbTE12A is a little unusual; a 
complex with N-RsbU is not (easily) 
detectable by the qualitative native gel 
electrophoresis assay, yet the Kd for this 
interaction by SPR is about double that of 
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wildtype. Furthermore, RsbTE12A cannot 
stimulate RsbU phosphatase activity. Perhaps 
RsbTE12 also contacts the C-terminal domain 
of RsbU (and/or the substrate, RsbV-P), which 
of course could not be measured with the 
isolated N-terminal domain of RsbU as the 
ligand.  
 
The first description of ‘partner-switching’ 
was between the B. subtilis sporulation sigma 
factor, σF and SpoIIAB, the anti-sigma, and 
SpoIIAA, the anti-anti-sigma factor (44,45). 
This system is extremely-well characterised 
(46). Structural analysis of the σF:SpoIIAB 
and SpoIIAA:SpoIIAB complexes has 
revealed some features of this system that are 
distinct from the N-RsbU:RsbT and N-
RsbR:RsbT interactions. For instance, σF and 
SpoIIAA have no sequence homology and this 
is mirrored by their 3-dimensional structures, 
which are also discrete (47,48). Although the 
sequences of the N-terminal domains of RsbU 
and RsbR are unalike, their 3-D structures are 
highly similar (Figure 3e-f). Moreover, our 
analysis indicates that RsbT utilises a highly 
overlapped set of amino acids in the N-
terminal domains of both RsbR and RsbU, 
albeit with different chemical characteristics, 
to form its alternative complexes.  
 
By contrast, only one residue, R20 in SpoIIAB, 
equivalent to R19 in RsbT, can contact either 
σF or SpoIIAA (48). Other than for R20, the σF- 
and SpoIIAA-binding surfaces on SpoIIAB do 
not overlap (48). The binding footprint on 
SpoIIAB created by σF permits the 
simultaneous binding of SpoIIAA to cause 
release of σF because of the asymmetry of the 
SpoIIAB:σF complex – a dimer of SpoIIAB 
binds a monomer of σF (49,50). Therefore, one 
copy of SpoIIAB R20 is always available for 
SpoIIAA to gain a ‘toe-hold’ on SpoIIAB 
inducing release of σF. The highly overlapped 
surfaces on RsbT for its binding partners raise 
the possibility that a different, and arguably 
simpler, mechanism is utilised by the 
monomeric RsbT to effect partner-switching 
between stressosomes and RsbU. RsbT binds 
exclusively to one or the other of its partners, 
the identity of which would appear to depend 
purely on the phosphorylation state of the 
stressosome.  
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FOOTNOTES 
The atomic coordinates and structure factors (code 2J6Y, 2J6Z and 2J70 for N-RsbUE24K, N-RsbUY28I 
and N-RsbUI78K, respectively) have been deposited in the Protein Data Bank, Research Collaboratory 
for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (Http://www.rcsb.org).  
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FIGURE LEGENDS 
 
Figure 1. RsbT interaction with N-RsbU analysed by native PAGE. RsbT localises in the well of a 
12% acrylamide native gel (lane A); N-RsbUWT forms a distinct band towards the bottom of the well 
(lane B); a mixture of N-RsbUWT and RsbT results in a protein-protein complex being formed with a 
different migration rate to N-RsbU and RsbT (lane C). The remaining panels show the results of 
mixing wildtype RsbT with mutant N-RsbU proteins. 
 
Figure 2. Effect of mutations in RsbU on σB activity in vivo. Various strains of B. subtilis (Table 1) 
were grown in the absence (a) and presence (b) of 1 mM IPTG. The B. subtilis strains in both panels 
are: ■ BSM151 (wildtype); ● BSM154 (rsbU::kan); ? BSGH00 (rsbU::kan,Pspac,); ? BSGH01 
(rsbU::kan,Pspac::rsbU); ? BSGH02 (rsbU::kan, Pspac::rsbUE24K); ? BSGH03 (rsbU::kan, 
Pspac::rsbUY28I); ? BSGH05 (rsbU::kan, Pspac::rsbUI74Q); | BSGH06 (rsbU::kan, Pspac::rsbUI78K); ? 
BSGH07 (rsbU::kan, Pspac::rsbUS61L). The β-galactosidase activities are the mean values of three 
independent experiments.  
 
Figure 3. Crystallographic analysis of N-RsbU mutants. (a) The molecular surface of the N-RsbU 
dimer is coloured mostly blue. Surfaces coloured red correspond to residues targeted in this study as 
potential RsbT-interacting partners and are also conserved across RsbT encoding bacterial species; 
residues coloured green are conserved irrespective of the presence of rsbT in the genome and the 
orange line delineates the surface region of those amino acids that this study has revealed to mediate 
RsbT-binding in RsbU. The yellow surface represents S61, away from the proposed RsbT binding 
surface. Primes (’) are used to indicate that the residue in question comes from the 2nd protomer in the 
N-RsbU dimer. (b-d) OMIT electron density maps (each contoured at a level of 1 σ) associated with 
the structures of the N-RsbU mutants E24K (b), Y28I (c) and I78K (d). The final models are shown as 
solid ‘sticks’ with blue carbon atoms and with the wildtype structure at the mutated position with 
yellow carbon atoms. For E24K, 4 of the 5 independent copies of N-RsbU in the asymmetric unit have 
very similar sidechain conformations at position 24, all of which are displayed here after 
superimposition on molecule ‘A’. In all instances, the rotamer of the introduced side chain is one of 
the two most frequently-observed conformations in the COOT rotamer library (38). Ribbon ‘cartoons’ 
of N-RsbU (e) and N-RsbR (f) coloured blue and green, respectively; highlighted in red are the 
positions of mutations in both proteins that disrupt the binding of RsbT, indicating that a common 
surface is used. 
 
Figure 4. Partner-switching of RsbT. Wildtype and mutants of RsbT binding to (a) the RsbR:RsbS 
complex and (b) RsbU. RsbT proteins were each added to pre-purified RsbR:RsbS complex (a), and 
subjected to gel filtration. Shown in this panel are the first two, equivalent fractions across the void 
volume of the same gel filtration column for each RsbT mutant RsbR:RsbS mixture. RsbT mutants 
E12A, Q20A and Q36A retain RsbR:RsbS binding. The RsbT mutants were also assayed for N-RsbU 
binding (b) by native PAGE. 
 
Figure 5. Schematic of the environmental stress response. Pre-stress, the RsbT kinase is 
sequestered by the stressosome, represented here as a round disc with peripheral turrets. On the 
imposition of stress, the kinase activity of RsbT results in the phosphorylation of the stressosome and 
RsbT is released to interact with RsbU and stimulate its phosphatase function towards RsbV-P. 
Dephosphorylated RsbV attacks the RsbW:σB complex and liberates σB to bind to the crab-claw 
shaped core RNA polymerase (cRNAP) to form the holo-enzyme (hRNAP) that then transcribes the 
σB regulon. To reset the switch, the RsbX phosphatase must dephosphorylate the phosphorylated 
stressosome, which can then re-capture RsbT, down-regulating RsbU phosphatase activity. The 
kinase function of RsbW then predominates and RsbV is maintained in a phosphorylated form and σB 
is retained by RsbW. In the scheme, enzymatic activities are italicised, partner-switching modules 
linked by dashed arrows.  
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Table 1. Strains and plasmids used in this study 
 
 
Strain or plasmid Relevant genotype or features of plasmid Reference 
B. subtilis   
  168 trpC2 (26) 
  BSM151 trpC2 SPß ctc::lacZ erm cat 86 (27) 
  BSM154 trpC2 rsbU::kan SPß ctc::lacZ erm cat 86a (27) 
  BSGH00 trpC2 rsbU::kan pDG148 SPß ctc::lacZ erm cat 86 This study 
  BSGH01 trpC2 rsbU::kan pJPF01 SPß ctc::lacZ erm cat 86  This study 
  BSGH02 trpC2 rsbU::kan pJPF02 SPß ctc::lacZ erm cat 86  This study 
  BSGH03 trpC2 rsbU::kan pJPF03 SPß ctc::lacZ erm cat 86  This study 
  BSGH05 trpC2 rsbU::kan pJPF05 SPß ctc::lacZ erm cat 86  This study 
  BSGH06 trpC2 rsbU::kan pJPF06 SPß ctc::lacZ erm cat 86  This study 
  BSGH07 trpC2 rsbU::kan pJPF07 SPß ctc::lacZ erm cat 86 This study 
   
E. coli   
  DH5α supE44 ΔlacU169 (φ80lacZΔM15) hsdR17 recA1 endA1 
gyrA96 thi-1 relA1 
(51) 
  DH5αΤΜ T1R T1 phage resistant DH5α Invitrogen 
  BL21(DE3) F- ompT hsdSB(rB BB-mB-)gal dcm (DE3) Novagen 
   
Plasmids   
  pET11d amp lacI PT7lac Novagen 
  pET15b amp lacI PT7lac Novagen 
  pETNRsbU amp lacI PT7lac::rsbU1-112 (35) 
  pETRsbU amp lacI PT7lac::rsbU (19) 
  pDG148 bla kan pleo lacI Pspac (28) 
  pJPF01 bla kan pleo lacI Pspac::rsbU This study 
  pJPF02 bla kan pleo lacI Pspac::rsbU E24K This study 
  pJPF03 bla kan pleo lacI Pspac:rsbU: Y28I This study 
  pJPF05 bla kan pleo lacI Pspac::rsbU I74Q This study 
  pJPF06 bla kan pleo lacI Pspac::rsbU I78K This study 
  pJPF07 bla kan pleo lacI Pspac::rsbU S61A This study 
a The ctc-lacZ fusion in the SPß prophage is linked to the chloramphenicol (cat86) and erythromycin 
(erm) resistance genes 
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Table 2. Data collection and refinement statistics of N-RsbU mutant crystal structures 
 
 
 E24K Y28I I78K 
X-Ray source ESRF BM14 ESRF BM14 SRS 10.1 
Wavelength (Å) 0.933 0.933 1.488 
Detector MAR CCD MAR CCD MAR CCD 
Space Group C2 C2221 C2221
Unit cell: a, b, c (Å), [β (°)]a 100.2, 47.8, 95.0, [104.4] 42.9, 44.9, 77.5 42.1, 45.4, 76.7 
Resolution range (Å) 48.11-1.85b 28.8-1.95c 19.174-1.95d
No. of measurements 80138 39485 28355 
No. of unique reflections 35972 5862 5626 
Completeness (%) 96.1 (93.1) 100 (100) 99.2 (99.4) 
Redundancy 2.2 (2.2) 6.7 (6.9) 5.0 (5.0) 
Rsym 0.064 (0.437) 0.076 (0.353) 0.068 (0.223) 
I/(σ)I  5.3 (1.7) 7.3 (2.1) 6.4 (2.7) 
No. non-H atoms 3839 723 733 
Mean B factor all atoms (Å2) 19.9 22.0 26.4 
Rwork (x100) 18.1 21.8 19.5 
Rfree (x100) 25.3 29.4 27.9 
rmsd bond lengths (Å ) 0.022 0.022 0.021 
rmsd bond angles (°) 1.667 1.989 1.775 
 
a This value is only relevant for space group C2 
b Where values in parentheses refer to the highest resolution shell, 1.95-1.85 Å 
c Where values in parentheses refer to the highest resolution shell, 2.06-1.95 Å 
d Where values in parentheses refer to the highest resolution shell, 2.06-1.95 Å 
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Table 3. Disassociation constants of the N-RsbU:RsbT interactions 
 
N-RsbU proteins with RsbTWT  Kd (μM)*
Wildtype    2.14 ± 0.52 
Y18A     2.67 ± 0.56 
E24K     - 
Y28I     - 
Q31A     0.98 ± 0.12 
S34A     0.91 ± 0.04 
R35D     3.77 ± 0.23 
S61A     2.55 ± 0.25 
I74Q     - 
E75A     2.21 ± 0.31 
I78K     - 
M82Y     2.60 ± 0.60 
A83S     3.59 ± 0.38 
 
RsbT proteins with N-RsbUWT
E12A     3.71 ± 1.29 
R19A     - 
Q20A     2.10 ± 0.63 
R23A-N24A    - 
Q36A     3.97 ± 0.53 
 
* ± standard deviation 
- indicates that no binding could be detected and thus a Kd could not be determined 
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Table 4. Effects of mutations in RsbU and RsbT on RsbU phosphatase activity.  
Need the numbers from Steven for this table 
 
RsbU proteins with and without RsbTWT RsbU phosphatase activity* 
Wildtype     7.3 % ± 0.42 
Wildtype + RsbT    100.0 % ± 2.69 
E24K      7.8 % ± 1.51 
E24K + RsbT     7.4 % ± 0.57 
Y28I      13.8 % ± 7.00 
Y28I + RsbT     14.0 % ± 5.52 
Q31A      6.6 % ± 0.26 
Q31A + RsbT     176.8 % ± 8.63 
S61A      5.4 % ± 0.95 
S61A + RsbT     87.8 % ± 27.58 
I74Q      11.6 % ± 3.13 
I74Q + RsbT     13.5 % ± 3.08 
I78K      10.8 % ± 0.57 
I78K + RsbT     9.5 % ± 0.56 
 
Mutant RsbT proteins with RsbUWT
E12A       8.4 % ± 0.07 
R19A       10.0 % ± 3.96 
Q20A      242.5 % ± 22.06 
R23A-N24A      7.0 % ± 1.41 
Q36A       141.2 % ± 16.62 
 
*The RsbU phosphatase activity against its substrate, RsbV-P, was measured as a function of time for 
wildtype and mutants of RsbU and RsbT. The activity of RsbTWT-stimulated RsbUWT was taken to 
represent 100 %, and all other activities are scaled to this. Values in parentheses refer to the S.D. ± 
mean. 
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